(Q37582283)

21 August 2017

Minocycline augmentation of pharmacotherapy in obsessive-compulsive disorder: an open-label trial (English)

1 reference

obsessive-compulsive disorder

21 August 2017

0 references

0 references

1 reference

Carolyn I Rodriguez

1

1 reference

21 August 2017

James Bender

2

1 reference

21 August 2017

Sue M Marcus

3

1 reference

21 August 2017

Michael Snape

4

1 reference

21 August 2017

Moira Rynn

5

1 reference

21 August 2017

Helen Blair Simpson

6

1 reference

21 August 2017

1 September 2010

1 reference

The Journal of Clinical Psychiatry

21 August 2017

1 reference

21 August 2017

71

1 reference

21 August 2017

1247-1249

1 reference

21 August 2017

9

1 reference

Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Meta-analysis of the symptom structure of obsessive-compulsive disorder

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

A rating scale for depression

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

The assessment of anxiety states by rating

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Toward a neurobiology of obsessive-compulsive disorder

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Neuroprotection in Huntington's disease: a 2-year study on minocycline

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Viral-induced spinal motor neuron death is non-cell-autonomous and involves glutamate excitotoxicity.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Adults with early-onset obsessive-compulsive disorder.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3923525

Benefit-risk assessment of acne therapies

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20923629

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4088/JCP.09L05805BLU

1 reference

21 August 2017

1 reference

21 August 2017

1 reference